muur Heiligdom registreren daniel den hoed cancer center Canada Wanten beton
Stereotactic Body Radiotherapy: A Promising Treatment Option for the Boost of Oropharyngeal Cancers Not Suitable for Brachythera
Daniel den Hoed - Erasmus MC Foundation
Accrual Family Cancer Clinic Rotterdam (Dr Daniel den Hoed... | Download Scientific Diagram
Today's patients
Daniel den Hoed Fonds - Erasmus MC
Sternal Resection for Sarcoma, Recurrent Breast Cancer, and Radiation-Induced Necrosis
Nieuw Familiehuis Daniel den Hoed opent de deuren tegenover Erasmus MC - Nieuws - Erasmus MC
Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines. - Abstract - Europe PMC
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 6
Heating the patient: a promising approach?
Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancer
WMSM 2012 - Sexual dysfunction in the prostate cancer patient: Radiation therapy - Slide Presentation
Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature – topic of research paper in Clinical medicine. Download scholarly article PDF and read
The Dutch Deep Hyperthermia Trial: results in cervical cancer
Pelvic exenteration for primary and recurrent gynaecological malignancies
Glycolipids of human primary testicular germ cell tumours
Historie - Over radioloog Daniel den Hoed | Daniel den Hoed fonds
Familiehuis Daniel den Hoed | Rotterdam
Alveolar Soft Part Sarcoma: Should We Be Targeting the Tumor or Targeting the Vasculature?
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families
Response to adjuvant chemotherapy in primary breast cancer: no
Daniël den Hoed – Streekarchief Eiland IJsselmonde
Daniel den Hoedkliniek - Wikipedia
EFFECTS ON FUNCTIONAL OUTCOME AFTER IORT-CONTAINING MULTIMODALITY TREATMENT FOR LOCALLY ADVANCED PRIMARY AND LOCALLY RECURRENT R